Literature DB >> 25550463

The hypoxia-inducible miR-429 regulates hypoxia-inducible factor-1α expression in human endothelial cells through a negative feedback loop.

Sylwia Bartoszewska1, Kinga Kochan1, Arkadiusz Piotrowski1, Wojciech Kamysz1, Renata J Ochocka1, James F Collawn2, Rafal Bartoszewski2.   

Abstract

Hypoxia-inducible factors (HIFs) 1 and 2 are dimeric α/β transcription factors that regulate cellular responses to low oxygen. HIF-1 is induced first, whereas HIF-2 is associated with chronic hypoxia. To determine how HIF1A mRNA, the inducible subunit of HIF-1, is regulated during hypoxia, we followed HIF1A mRNA levels in primary HUVECs over 24 hours using quantitative PCR. HIF1A and VEGF A (VEGFA) mRNA, a transcriptional target of HIF-1, increased ∼ 2.5- and 8-fold at 2-4 hours, respectively. To determine how the mRNAs were regulated, we identified a microRNA (miRNA), miR-429, that destabilized HIF1A message and decreased VEGFA mRNA by inhibiting HIF1A. Target protector analysis, which interferes with miRNA-mRNA complex formation, confirmed that miR-429 targeted HIF1A message. Desferoxamine treatment, which inhibits the hydroxylases that promote HIF-1α protein degradation, stabilized HIF-1 activity during normoxic conditions and elevated miR-429 levels, demonstrating that HIF-1 promotes miR-429 expression. RNA-sequencing-based transcriptome analysis indicated that inhibition of miRNA-429 in HUVECs up-regulated 209 mRNAs, a number of which regulate angiogenesis. The results demonstrate that HIF-1 is in a negative regulatory loop with miR-429, that miR-429 attenuates HIF-1 activity by decreasing HIF1A message during the early stages of hypoxia before HIF-2 is activated, and this regulatory network helps explain the HIF-1 transition to HIF-2 during chronic hypoxia in endothelial cells. © FASEB.

Entities:  

Keywords:  HIF-2; VEGF A; angiogenesis; hypoxamiR; miRNA

Mesh:

Substances:

Year:  2014        PMID: 25550463      PMCID: PMC4396612          DOI: 10.1096/fj.14-267054

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  68 in total

1.  Hypoxia-inducible transcription factor-1 alpha determines sensitivity of endothelial cells to the proteosome inhibitor bortezomib.

Authors:  Lorenzo Veschini; Daniela Belloni; Chiara Foglieni; Maria Giulia Cangi; Marina Ferrarini; Federico Caligaris-Cappio; Elisabetta Ferrero
Journal:  Blood       Date:  2006-11-16       Impact factor: 22.113

2.  A microRNA signature of hypoxia.

Authors:  Ritu Kulshreshtha; Manuela Ferracin; Sylwia E Wojcik; Ramiro Garzon; Hansjuerg Alder; Francisco J Agosto-Perez; Ramana Davuluri; Chang-Gong Liu; Carlo M Croce; Massimo Negrini; George A Calin; Mircea Ivan
Journal:  Mol Cell Biol       Date:  2006-12-28       Impact factor: 4.272

3.  Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts.

Authors:  R D Thornton; P Lane; R C Borghaei; E A Pease; J Caro; E Mochan
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

4.  Identification of mRNAs that continue to associate with polysomes during hypoxia.

Authors:  Jeff D Thomas; Gregg J Johannes
Journal:  RNA       Date:  2007-05-08       Impact factor: 4.942

5.  Protein kinase C-mediated modulation of FIH-1 expression by the homeodomain protein CDP/Cut/Cux.

Authors:  Jinping Li; Enfeng Wang; Shamit Dutta; Julie S Lau; Shi-wen Jiang; Kaustubh Datta; Debabrata Mukhopadhyay
Journal:  Mol Cell Biol       Date:  2007-08-06       Impact factor: 4.272

6.  Expression of endothelial cell-specific molecule-1 regulated by hypoxia inducible factor-1α in human colon carcinoma: impact of ESM-1 on prognosis and its correlation with clinicopathological features.

Authors:  Joo Heon Kim; Mee Young Park; Chang Nam Kim; Kyo Hyun Kim; Ho Bum Kang; Kwang Dong Kim; Jae Wha Kim
Journal:  Oncol Rep       Date:  2012-09-03       Impact factor: 3.906

7.  Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia.

Authors:  Marta Bosch-Marce; Hiroaki Okuyama; Jacob B Wesley; Kakali Sarkar; Hideo Kimura; Ye V Liu; Huafeng Zhang; Marianne Strazza; Sergio Rey; Lindsey Savino; Yi Fu Zhou; Karin R McDonald; Youn Na; Scott Vandiver; Alireza Rabi; Yuval Shaked; Robert Kerbel; Theresa Lavallee; Gregg L Semenza
Journal:  Circ Res       Date:  2007-10-11       Impact factor: 17.367

8.  Mangiferin has an additive effect on the apoptotic properties of hesperidin in Cyclopia sp. tea extracts.

Authors:  Rafal Bartoszewski; Anna Hering; Marcin Marszałł; Justyna Stefanowicz Hajduk; Sylwia Bartoszewska; Niren Kapoor; Kinga Kochan; Renata Ochocka
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

9.  BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression.

Authors:  L Persano; F Pistollato; E Rampazzo; A Della Puppa; S Abbadi; C Frasson; F Volpin; S Indraccolo; R Scienza; G Basso
Journal:  Cell Death Dis       Date:  2012-10-18       Impact factor: 8.469

Review 10.  Regulation of angiogenesis by hypoxia: the role of microRNA.

Authors:  Piotr Madanecki; Niren Kapoor; Zsuzsa Bebok; Renata Ochocka; James F Collawn; Rafal Bartoszewski
Journal:  Cell Mol Biol Lett       Date:  2012-11-03       Impact factor: 5.787

View more
  48 in total

1.  Correlation of two distinct metastasis-associated proteins, MTA1 and S100A4, in angiogenesis for promoting tumor growth.

Authors:  Mizuho Ishikawa; Mitsuhiko Osaki; Makoto Yamagishi; Kunishige Onuma; Hisao Ito; Futoshi Okada; Hideya Endo
Journal:  Oncogene       Date:  2019-02-11       Impact factor: 9.867

Review 2.  miRNA in Macrophage Development and Function.

Authors:  Sashwati Roy
Journal:  Antioxid Redox Signal       Date:  2016-08-19       Impact factor: 8.401

3.  miR-200b downregulates Kruppel Like Factor 2 (KLF2) during acute hypoxia in human endothelial cells.

Authors:  Rafal Bartoszewski; Marcin Serocki; Anna Janaszak-Jasiecka; Sylwia Bartoszewska; Kinga Kochan-Jamrozy; Arkadiusz Piotrowski; Jarosław Króliczewski; James F Collawn
Journal:  Eur J Cell Biol       Date:  2017-10-13       Impact factor: 4.492

4.  MicroRNA-138 inhibits hypoxia-induced proliferation of endothelial progenitor cells via inhibition of HIF-1α-mediated MAPK and AKT signaling.

Authors:  Wei Zhou; Weimin Zhou; Qingzhong Zeng; Jixin Xiong
Journal:  Exp Ther Med       Date:  2017-01-27       Impact factor: 2.447

5.  The hypoxia-induced changes in miRNA-mRNA in RNA-induced silencing complexes and HIF-2 induced miRNAs in human endothelial cells.

Authors:  Adrianna Moszyńska; Maciej Jaśkiewicz; Marcin Serocki; Aleksandra Cabaj; David K Crossman; Sylwia Bartoszewska; Magdalena Gebert; Michał Dąbrowski; James F Collawn; Rafal Bartoszewski
Journal:  FASEB J       Date:  2022-07       Impact factor: 5.834

Review 6.  Dysregulation of non-coding RNAs in gastric cancer.

Authors:  Qing Yang; Ren-Wen Zhang; Peng-Cheng Sui; Hai-Tao He; Lei Ding
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

7.  Primary endothelial cell-specific regulation of hypoxia-inducible factor (HIF)-1 and HIF-2 and their target gene expression profiles during hypoxia.

Authors:  Rafal Bartoszewski; Adrianna Moszyńska; Marcin Serocki; Aleksandra Cabaj; Andreas Polten; Renata Ochocka; Louis Dell'Italia; Sylwia Bartoszewska; Jarosław Króliczewski; Michał Dąbrowski; James F Collawn
Journal:  FASEB J       Date:  2019-03-27       Impact factor: 5.191

8.  Effect of Nanog overexpression on the metastatic potential of a mouse melanoma cell line B16-BL6.

Authors:  Mikako Saito; Ryota Kishi; Tomoko Sasai; Tomohiro Hatakenaka; Nahoko Matsuki; Seiya Minagawa
Journal:  Mol Cell Biochem       Date:  2021-03-04       Impact factor: 3.396

9.  [Effects of hypoxia-inducible factor 1α on hypoxic tolerance of human amniotic mesenchymal stem cells].

Authors:  Lihao Ge; Deshui Yu; Ruichao Su; Yang Cao
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2018-03-15

Review 10.  Hypoxia-inducible factor as an angiogenic master switch.

Authors:  Takuya Hashimoto; Futoshi Shibasaki
Journal:  Front Pediatr       Date:  2015-04-24       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.